Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Current Deferred Tax Assets: 2020-2023

  • Universe Pharmaceuticals' Current Deferred Tax Assets rose 9587190.43% to $728.1 billion in Q1 2023 from the same period last year, while for Mar 2023 it was $728.1 billion, marking a year-over-year increase of 9587190.43%. This contributed to the annual value of $702.9 billion for FY2022, which is 9381373.30% up from last year.
  • Per Universe Pharmaceuticals' latest filing, its Current Deferred Tax Assets stood at $728.1 billion for Q1 2023, which was up 3.58% from $702.9 billion recorded in Q3 2022.
  • In the past 5 years, Universe Pharmaceuticals' Current Deferred Tax Assets registered a high of $728.1 billion during Q1 2023, and its lowest value of $7.5 million during Q3 2021.
  • Over the past 3 years, Universe Pharmaceuticals' median Current Deferred Tax Assets value was $351.4 billion (recorded in 2022), while the average stood at $357.7 billion.
  • Per our database at Business Quant, Universe Pharmaceuticals' Current Deferred Tax Assets slumped by 100.00% in 2021 and then soared by 9,587,190.43% in 2023.
  • Universe Pharmaceuticals' Current Deferred Tax Assets (Quarterly) stood at $443.7 billion in 2020, then slumped by 100.00% to $7.5 million in 2021, then skyrocketed by 9,381,373.30% to $702.9 billion in 2022, then spiked by 9,587,190.43% to $728.1 billion in 2023.
  • Its Current Deferred Tax Assets stands at $728.1 billion for Q1 2023, versus $702.9 billion for Q3 2022 and $7.6 million for Q1 2022.